ACCESSWIRE
09 May 2022, 21:13 GMT+10
CAMBRIDGE, MA / ACCESSWIRE / May 9, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that that it will host its in-person Science and Technology Day for analysts and investors at 9:00 a.m. ET on Tuesday, May 17 in Boston, MA.
Moderna's Science and Technology Day will feature presentations from Stephen Hoge M.D., President, Melissa Moore Ph.D., Chief Scientific Officer, Scientific Affairs, and Moderna's mRNA and technical development platform scientists with a focus on the Company's newest advances from its commitment to basic and applied sciences.
A live webcast will be available under the 'Events and Presentations' in the Investors section of the Moderna website at investors.modernatx.com. A replay of the webcast will be archived on Moderna's website for one year following the presentation.
About Moderna
In over 10 years since its inception, Moderna has transformed from a research-stage company advancing programs in the field of messenger RNA (mRNA) to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for rapid clinical and commercial production at scale. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna's capabilities have come together to allow the authorized use and approval of one of the earliest and most effective vaccines against the COVID-19 pandemic.
Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past seven years. To learn more, visit www.modernatx.com.
Moderna Contact:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
Get a daily dose of Cleveland Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Cleveland Star.
More InformationSYDNEY, NSW, Australia - A potential easing of the Chinese government's crackdown on technology companies drove stocks in Hong Kong ...
KATHMANDU, Nepal - The governments of Nepal and India have signed a bilateral memorandum of understanding for the construction of ...
LOS ANGELES, California: Kia has become the second largest manufacturer of electric vehicles sold in the United States, second only ...
NEW YORK, New York - Weak economic news out of China undermined stocks on Wall Street on Monday. The major ...
ATLANTA, Georgia: Mercedes-Benz USA has requested drivers to stop driving some of their autos immediately due to braking problems.The announcement ...
KARACHI, Pakistan - The U.S. dollar climbed past Rs194 in the interbank market in Pakistan on Monday as analysts expressed ...
NEW YORK CITY, New York: Amazon.com founder Jeff Bezos delivered a tearful remembrance of his father's fleeing Cuba in the ...
It never rains in California, or so it is said, which means that Tuesday's doubleheader between the visiting Arizona Diamondbacks ...
An emergency protector order was granted by Jefferson County Family Court in Louisville on Friday, two days after the alleged ...
The Cleveland Guardians dealt for right-handed relief pitcher Yohan Ramirez from the Seattle Mariners on Monday in exchange for cash ...
The two-time reigning Stanley Cup champions against the recently crowned Presidents' Trophy winners -- that's the juicy matchup set for ...
Free agent wide receiver Antonio Brown took to social media Monday, saying he wants to retire as a member of ...